Tackle gene therapy manufacturing challenges with confidence.

This week's Fierce Biotech is brought to you by Avantor.

Novel Cell Lysis Solution: Scaling up the harvest process while preserving what matters

The promise of gene therapy is undeniable, but manufacturing hurdles remain.
As viral gene therapy scales to address inherited disorders and diseases, traditional chemical lysis methods reveal significant limitations—high viscosity, foaming, and risks to viral particle integrity. Now, there’s a novel cell lysis solution designed to overcome these challenges while prioritizing scalability, efficiency, and environmental impact. What’s inside this free whitepaper?

Download the whitepaper now to learn how this ready-to-use, highly concentrated reagent is setting a new standard in gene therapy manufacturing. Simplify your process, protect what matters, and scale up with confidence.